In a single experiment, scientists can decipher the entire genomes of many patient samples, animal models, or cultured cells.

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent ...

Phase 1b translational data demonstrate localized ileocolonic target engagement, suppression of inflammatory and fibrotic gene programs, and early clinical response within seven days Encouraging ...

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...

BlueRock Therapeutics, a Bayer subsidiary developing stem cell treatments for Parkinson’s disease, has partnered with Rune ...

The BioWorld Biopharmaceutical Index finished 2025 up 24.07%, building slightly on its 23% gain recorded at the end of November. While the increase trailed the Nasdaq Biotechnology Index’s 32.4% rise ...

DNA storage has always attracted a lot of interest due of its potential density and longevity - and researchers have long been exploring ways to encode digital information into DNA strands that can be ...

About Hub Cyber Security Ltd. Mount Rainier Acquisition Corp. operates as a blank check company. It is a special purpose acquisition company which is incorporated for the purpose of effecting a merger ...

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life ...